Pharmaceuticals and Medical Devices Agency (PMDA)'s New Action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy

DOI Web Site Web Site PubMed

Bibliographic Information

Other Title
  • 医薬品医療機器総合機構（PMDA）で新たに開始した薬事戦略相談事業について
  • イヤクヒン イリョウ キキ ソウゴウ キコウ(PMDA)デ アラタ ニ カイシ シタ ヤクジ センリャク ソウダン ジギョウ ニ ツイテ

Search this article

Abstract

  Universities, research institutions, and venture capitals that possess promising “seed” research or technologies in Japan, are not always familiar with development strategies that lead to commercialization of the products in spite of their excellent science and research. In order to create innovative pharmaceuticals and medical devices originating from Japan, Pharmaceuticals and Medical Devices Agency (PMDA) launched new scientific consultation service, named ‘Pharmaceutical Affairs Consultation on R&D Strategy’ for universities, research institutions, and venture capitals on July 1, 2011. Through these consultations, the guidance and advice on the tests needed in the early development stage and the necessary clinical trials would be provided toward commercialization.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 133 (2), 183-186, 2013-02-01

    The Pharmaceutical Society of Japan

Keywords

Details 詳細情報について

Report a problem

Back to top